Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile Health Intervention for HIV/AIDS
N/A
Waitlist Available
Led By Judy Y Tan, Ph.D.
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
Summary
This trial will test a new mobile health intervention called LetSync to see if it is acceptable and feasible, and if it improves retention in care and antiretroviral adherence.
Who is the study for?
This trial is for cisgender men over 18 in a committed relationship, who are racial/ethnic minorities living with HIV or have a partner who is. They must own and use a smartphone and be willing to consent to the study. It's not for those fearing intimate partner violence from participating or unable to disclose their HIV status.
What is being tested?
The LetSync mHealth intervention is being tested on couples where at least one partner has HIV. The study will see if using the app helps them stay on track with their treatment and care. Participants will first try version 1.0, then some will test an updated version after feedback.
What are the potential side effects?
Since this trial involves an mHealth app rather than medication, traditional side effects aren't expected; however, participants may experience privacy concerns or stress related to adherence monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Levels of Antiretroviral (ARV) concentration in dried blood spot (DBS) samples
Presence of Antiretroviral (ARV) medication in urine sample
Self-reported measure I of antiretroviral therapy (ART) adherence
+2 moreSecondary study objectives
Acceptability of or Satisfaction in using LetSync app v1.0
Feasibility or usability of LetSync app v1.0 (how easy or convenient is v1.0 to use)
Self-reported care engagement
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This arm will start the intervention using LetSync app v1.0 from T1 to T4, baseline/Month 0 to Month 14.
Group II: Waitlist-Control GroupActive Control1 Intervention
This arm will wait to begin the intervention using the LetSync app v2.0 from T3 to T4, Month 8 to Month 14.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,551 Previous Clinical Trials
15,257,726 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,869 Previous Clinical Trials
2,777,376 Total Patients Enrolled
Judy Y Tan, Ph.D.Principal InvestigatorUniversity of California, San Francisco
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are afraid that participating in the study could result in violence from your partner, you cannot or will not tell your primary partner about your HIV status, or you have severe memory problems that would make it hard for you to understand what is involved in the study.You can participate in the study if you are 18 years or older, identify as a racial/ethnic minority, identify as a cisgender man, are HIV-positive or have a partner who is HIV-positive, have a committed primary relationship for more than 3 months, own a smartphone, and are willing to give consent.
Research Study Groups:
This trial has the following groups:- Group 1: Waitlist-Control Group
- Group 2: Intervention Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger